CEV is proud to inform that ProBlad™´s active ingredient was approved by the European Union (EU) as a “Low-Risk Active Substance” under Regulation (EC) No.1107/2009. The formal name of the active substance, under EU regulations, is known as “aqueous extract from the germinated seeds of sweet Lupinus albus”.
This is a great milestone as it has required huge scientific and laboratorial work, numerous efficacy trials, along with massive regulatory workloads, resilient behavior from CEV´s team and strong financial support from CEV’s investors.
This goal was only possible to achieve by CEV, because of its right partners that ensured the success of this long technical process. CEV thanks all of them for their great efforts, namely its competent and professional internal scientific and regulatory staff, the high-standard contracted consultants and laboratories, the unique commercial team, and finally, the strong and confident shareholders.
